Detalhe da pesquisa
1.
Long-term trajectories of ambulatory impairment in multiple sclerosis.
Mult Scler
; 29(10): 1282-1295, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37503861
2.
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis.
Curr Opin Neurol
; 34(4): 598-603, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33990101
3.
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.
Mult Scler
; 26(12): 1581-1589, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31368401
4.
Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge.
Am J Physiol Endocrinol Metab
; 314(4): E406-E412, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29138226
5.
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
Mult Scler
; 24(11): 1469-1484, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28799444
6.
Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute.
Psychosomatics
; 59(4): 369-378, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29580558
7.
Refinement of an Instrument to Measure the Needs of Parents of Sick Children in the Context of Family Centered Care.
J Pediatr Nurs
; 43: 77-87, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30473160
8.
Assessing diagnosis disclosure and concealment in multiple sclerosis: Building a framework for moving forward.
Mult Scler
; 28(2): 171-172, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35014561
9.
Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting.
Mult Scler
; 23(14): 1929-1937, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28080262
10.
Idio Scale Judgment: evaluation of a new method for estimating responder thresholds.
Qual Life Res
; 26(11): 2961-2971, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28624901
11.
Linearity of ß-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series.
Am J Physiol Endocrinol Metab
; 310(11): E865-73, 2016 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27072496
12.
Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis.
Mult Scler
; 22(6): 830-41, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26238464
13.
Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database.
Mult Scler
; 21(4): 457-65, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25112816
14.
Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers.
Qual Life Res
; 24(3): 575-89, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25148759
15.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
J Behav Med
; 38(2): 237-50, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24880636
16.
Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life.
J Neuroophthalmol
; 35(1): 6-11, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25370598
17.
A meta-analysis of confidence and judgment accuracy in clinical decision making.
J Couns Psychol
; 62(4): 553-67, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26280710
18.
Disposition and metabolism of the cathepsin K inhibitor odanacatib in humans.
Drug Metab Dispos
; 42(5): 818-27, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24553380
19.
Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.
Epilepsy Behav
; 31: 77-84, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24361767
20.
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab.
Neurodegener Dis Manag
; 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38623894